Scandion Oncology
Overcoming cancer drug resistance

Navbar

About us
Research & Development
News & Press
- Press releases
- Media
  - Image library
  - Video library
Investors
Contact
- Career

Skip to content

Loading view.

Investor meetings

Events
Investor meetings

Events Search and Views Navigation

Enter Keyword. Search for Events by Keyword.

Event Views Navigation

List
Month
Day

Select date.

Filters

Changing any of the form inputs will cause the list of events to refresh with the filtered results.

Category

City

All Day

14 June, 2022

Aktiespararna Småbolagsdagarna 2022

Stockholm

Meet Scandion Oncology at Aktiespararna Småbolagsdagarna 2022

Previous Day
Next Day

Google Calendar
iCalendar
Outlook 365
Outlook Live
Export .ics file
Export Outlook .ics file

Frontpage
Calendar
List

About us

About us
Executive Management
Board of Directors
Clinical Advisory Board

Research & Development

Research & Development
Pipeline
Clinical Development
Science

News & Press

Press releases
Other news
Media
- Image library items
- Video library items

Investors

Investors
Share information
Financial Reports
Presentations
Analyst Coverage
Prospectuses
Corporate governance
Events

Contact us

Scandion Oncology A/S
Symbion
Fruebjergvej 3
2100 Copenhagen
Denmark

Phone: +45 38 10 20 17
info@scandiononcology.com

Media and Investor relations:
Email: ir@scandiononcology.com
Phone: +45 29 60 35 32

Follow us

Scandion Oncology - The Cancer Drug Resistance Company

Our vision is to overcome cancer drug resistance in order to improve lives for cancer patients and their families

© Copyright 2022 - Scandion Oncology A/S | We use cookies to improve our services | Disclaimer: Market data could be delayed. Delivered by Cision.